NCT05329363 Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
| NCT ID | NCT05329363 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Tours |
| Condition | Schizophrenia |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-06-17 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-06-17 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms. Psychoeducation can improve therapeutic alliance and medication compliance. In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation. The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years * Patient with a diagnosed and reported schizophrenic disorder announced : * Schizophrenia * Schizoaffective disorder * Or a diagnosed and reported Delusional Disorder * Express written consent by the participant after receiving information about the study * Be able to communicate verbally * Participant affiliated to a social security scheme Exclusion Criteria: * Pregnant or breastfeeding woman * Patient who does not speak French * Participation in a psycho-education group in the last 2 years * Patient under legal protection or guardianship
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05329363 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Schizophrenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05329363 currently recruiting?
Yes, NCT05329363 is actively recruiting participants. Contact the research team at A.CHESSE@chu-tours.fr for enrollment information.
Where is the NCT05329363 trial being conducted?
This trial is being conducted at Blois, France, Chinon, France, Dreux, France, Fleury-les-Aubrais, France and 7 additional locations.
Who is sponsoring the NCT05329363 clinical trial?
NCT05329363 is sponsored by University Hospital, Tours. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.